Kick off of the 2024 #DAVAbreast davaonc.com/davabreast2024 with Hawaiian oli blessing. 175 talks on novel therapeutics in #breastcancer

#davabreast George Sledge speaks to the future of breast cancer research. Always love and learn from listening to his talks!

Thank you for your unwavering support throughout this journey MinhTri Nguyen, MD (he/him)

Wonderful talk by Nicole Williams MD on Considerations for an Older Frail Patient with ER+ Breast Cancer at DAVA Oncology #DAVABreast Ohio State Medical Oncology The James Ohio State WIMS #GeriOnc

Excited to see our review published! Thank you Jame Abraham, MD, FACP and Erin Roesch for all your guidance and support! JCO Oncology Practice

Starting Now: Cellular Therapies and Vaccine Strategies Moderated by: Dr. Priyanka Sharma KU Medical Center #DAVABreast

It was purely a business meeting, I assure you. Fun was not had. :) #DAVABrest DAVA Oncology Nicole Williams MD Nerea Lopetegui-Lia, MD Paolo Tarantino Megan Kruse #bcsm

Starting Now: Lobular Breast Carcinoma Moderated by: Eric Winer, MD #DAVABreast

Megan Kruse with a poignant presentation regarding limited data for the treatment of leptomeningeal disease in lobular breast cancer; but novel systemic agents hold promise in ongoing trials!

Ana Garrido-Castro from Dana-Farber’s Breast Oncology Center reviews available clinical data and ongoing developments with the Trop2 ADC Sacituzumab Tirumotecan at #DAVABreast.

Today, my PhD advisor and mentor, Nacho Mata, received the Diversity and Inclusion Award at the Cleveland Clinic Lerner Research Institute Excellence Award Ceremony! Your commitment to inclusion and diversity, both in and out of the lab, inspires us all. Congratulations on this well-deserved recognition! 🏆👏🏼

consultqd.clevelandclinic.org/new-cellular-a…

👋Welcome Arya Roy to the The James Medical Oncology team! We are excited to work with you!

Great job Daniel Stover, MD, FASCO 🎉

📝New publication from Daniel Stover, MD, FASCO & colleagues: Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502 doi.org/10.1038/s41523…

Amazing work, Daniel Stover, MD, FASCO 👏🏻👏🏻

🔥HOT OFF THE🗞️PRESS in npj Journals w/ Johns Hopkins Kimmel Cancer Center "Complete morphologic response to gilteritinib in ALK-rearranged acute myeloid leukemia"‼️ Astellas Pharma US Gilteritinib is a POTENT💊ALK inhibitor and inv(2)🧬creates constitutively active ALK😲‼️bit.ly/3AZlvfw

🚀Join us for an in-depth live webinar update on Breast Cancer Developments with Joyce O'Shaughnessy, MD on Oct 2nd at 8PM EST! Register now: share.hsforms.com/1CYtiJF0_RxesM…